50-23-7 | Cortisol

Chemical type

• Endogenous steroid hormone (glucocorticoid)

^[1]

• Glucocorticoid steroid hormone

^[2]

Key properties

• Regulates glucose metabolism
• Increases insulin resistance
• Affects blood pressure, immune response, and bone metabolism

^[1]

• Excess causes symptoms like hypertension, diabetes, muscle weakness, and hypokalemia
• Measured in serum, urine (free cortisol), and saliva
• Fails to suppress with dexamethasone in Cushing syndrome

^[2]

• Physiological stress hormone
• Clinical biomarker for hypercortisolism and Cushing’s syndrome

^[1]

• Diagnostic marker (e.g., 24-hour urinary free cortisol, late-night salivary cortisol)
• Therapeutic administration (e.g., stress doses during surgery)
• Postoperative replacement in adrenal insufficiency

^[2]

Classification by use

• Chemicals used as endocrine biomarkers
• Chemicals involved in glucose metabolism regulation
• Chemicals involved in stress response

^[1]

• Steroid hormones for endocrine disorders
• Anti-inflammatory and immunosuppressive agents

^[2]

A trustworthy factory and manufacturer

Demei Chemical Technology Co., Ltd. is a modern high-tech enterprise integrating R&D, production, and sales. The company's founder, Dr. Arron, born in April 1975, graduated from the School of Mechanical Engineering at Yanshan University and has been engaged in research in the fields of mechanical engineering and chemical synthesis for many years. The company's products focus on the chemical industry, primarily dealing in chemical raw materials and chemical production machinery and equipment. With its strong technical capabilities, advanced production equipment, and strict quality management system, the company has earned the trust of customers worldwide.

1. [Cite:1] Insulin Resistance Unveiled: Cushing's Disease in a Patient with Type 1 Diabetes Mellitus and Worsening Glycemic Control, AACE Endocrinology and Diabetes, 5 January 2026
2. [Cite:2] Ectopic Cushing Syndrome due to an Adrenocorticotropic Hormone-Producing Pheochromocytoma, AACE Endocrinology and Diabetes, 2 January 2026